1. Docosahexaenoic Acid in the Inhibition of Tumor Cell Growth in Preclinical Models of Ovarian Cancer
- Author
-
Lynne-Marie Postovit, Julia Schueler, Armin M. Gamper, Amirali B. Bukhari, Olena Bilyk, Bahareh Hamedi, Indrani Dutta, Gabrielle M. Siegers, Rojine C. McVea, Catherine J. Field, Jiahui Liu, and Marnie Newell
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,Docosahexaenoic Acids ,genetic structures ,Medicine (miscellaneous) ,Tumor cells ,Carcinoma, Ovarian Epithelial ,Carboplatin ,Mice ,Nutritional Interventions ,Internal medicine ,medicine ,Animals ,Humans ,Cell Proliferation ,Ovarian Neoplasms ,Nutrition and Dietetics ,Cancer prevention ,business.industry ,Cell Cycle ,food and beverages ,medicine.disease ,Disease Models, Animal ,Docosahexaenoic acid ,Female ,lipids (amino acids, peptides, and proteins) ,business ,Ovarian cancer - Abstract
There is a strong rationale for investigating nutritional interventions with docosahexaenoic acid (DHA) in cancer prevention and therapy; however, the effects of DHA on ovarian cancer (OC) have not...
- Published
- 2021
- Full Text
- View/download PDF